The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Antibody therapy
Antibody therapy
Monoclonal antibodies target antigens expressed by malignant cells, making them more selective than chemotherapy. Antibodies can induce the innate immune response to destroy tumor cells, or block key extracellular sites such as receptors to induce cancer cell death. In MM, target antigens include BCMA, CD20, CD38, CD40, PD-1, and VEGF.
|
|
|